The latest closing stock price for Rapport Therapeutics as of March 28, 2025 is 10.05.
An investor who bought $1,000 worth of Rapport Therapeutics stock at the IPO in 2024 would have $-517 today, roughly -1 times their original investment - a -51.68% compound annual growth rate over 1 years.
The all-time high Rapport Therapeutics stock closing price was 29.23 on October 16, 2024.
The Rapport Therapeutics 52-week high stock price is 29.74, which is 195.9% above the current share price.
The Rapport Therapeutics 52-week low stock price is 6.43, which is 36% below the current share price.
The average Rapport Therapeutics stock price for the last 52 weeks is 19.35.
An investor who bought $1,000 worth of Rapport Therapeutics stock at the IPO in 2024 would have $-517 today, roughly -1 times their original investment - a -51.68% compound annual growth rate over 1 years.
The all-time high Rapport Therapeutics stock closing price was 29.23 on October 16, 2024.
The Rapport Therapeutics 52-week high stock price is 29.74, which is 195.9% above the current share price.
The Rapport Therapeutics 52-week low stock price is 6.43, which is 36% below the current share price.
The average Rapport Therapeutics stock price for the last 52 weeks is 19.35.